WO1994011051A1 - Large diameter vasoocclusion coil - Google Patents

Large diameter vasoocclusion coil Download PDF

Info

Publication number
WO1994011051A1
WO1994011051A1 PCT/US1993/000882 US9300882W WO9411051A1 WO 1994011051 A1 WO1994011051 A1 WO 1994011051A1 US 9300882 W US9300882 W US 9300882W WO 9411051 A1 WO9411051 A1 WO 9411051A1
Authority
WO
WIPO (PCT)
Prior art keywords
coil
helical coil
helical
vessel
shaped structure
Prior art date
Application number
PCT/US1993/000882
Other languages
French (fr)
Inventor
U. Hiram Chee
Mike Mariant
Erik T. Engelson
Original Assignee
Target Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Target Therapeutics, Inc. filed Critical Target Therapeutics, Inc.
Priority to CA002144725A priority Critical patent/CA2144725C/en
Priority to EP93904799A priority patent/EP0743866A1/en
Priority to AU36037/93A priority patent/AU681073B2/en
Priority to JP6512040A priority patent/JPH08500273A/en
Publication of WO1994011051A1 publication Critical patent/WO1994011051A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
    • A61B17/12113—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/1214—Coils or wires
    • A61B17/12145—Coils or wires having a pre-set deployed three-dimensional shape
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39—Markers, e.g. radio-opaque or breast lesions markers

Definitions

  • This invention is in the general field of surgical instruments. More particularly, it relates to a vasoocclusion device that can be used in cardiovascular and endovascular procedures.
  • Vasoocclusion devices are surgical implements that are placed within vessels, typically via a catheter, to block the flow of blood through the vessel.
  • Vasoocclusive coils have been used to occlude vessels in small-diameter, difficult to reach sites.
  • United States Patent No. 4,994,069 provides a vasoocclusive wire that is guided to a vessel that has a diameter of between 0.5 and 6 mm.
  • the patent describes a flexible vasoocclusive wire that is designed to occlude a vessel when the wire is released into the vessel.
  • the diameter of the coiled wire is between about 10-30 mils, the wire itself has an outside diameter of between about 2-6 mils and there are about 4-8 helical windings.
  • the wire has a preferred length of about 3-6 cm, and for a vessel that is 2-6 mm, the wire has a preferred length of about 5-10 cm.
  • the device is a vasoocclusive coil that assumes a linear helical
  • the stretched condition is used in placing the coil at the desired site and the coil assumes its relaxed configuration once the device is so placed.
  • the vasoocclusive device is a helical coil having a multiplicity of windings between a first and second end wherein the primary coil diameter is between about 0.25 and 1.5 mm and the diameter of the vessel to be occluded is between about 1.0 and 3.0 cm. Once relaxed, the coil may assume a secondary coil diameter approaching that of the selected vessel.
  • Figs. 1 to 9 are fragmentary elevational views (not to scale) of embodiments of the helical coil of the invention.
  • Fig. 1 depicts one embodiment, generally designated 10, of the helical vasoocclusive coil of the invention.
  • the helical coil 10 will typically be made of a radiopaque material such as platinum, tungsten, gold, stainless steel, or of alloys such as tungsten and platinum.
  • a tungsten-platinum alloy is preferred because of its strength and toughness.
  • the material desirably is radiopaque and the diameter of the wire will usually be in the range of 0.05 to 0.25 mm.
  • the coil has a
  • the axial length of the coil will usually be in the range of 0.2 to 100 cm, more usually 0.2 to 40 cm and the diameter of the coil will normally be 0.25 and 1.5 mm, more usually 0.5 to 1.0 mm.
  • the coil will typically have about 40 to 200 windings per cm, more typically about 50 to 130 windings per cm.
  • the steps in the construction of the vasoocclusion coils of this invention are shown in Figs. 1-3.
  • the coil itself may be formed by wrappings of windings of a fine radiopaque wire thread, preferably 5 to 8 mil (0.13 to 0.20 mm) platinum, tungsten, gold, stainless steel or alloy thread which is available, for example, from California Fine Wire Company (Grover City, CA).
  • the windings are preferably made by wrapping the thread on a spinning mandrel, according to known coilmanufacturing methods.
  • the wire advance on the mandrel is adjusted to produce a single-layer coil with a minimum helical pitch, i.e., in which the windings are closely packed.
  • the mandrel has a diameter of between about 0.10 and 1.0 mm yielding a coil whose outer
  • the soft, flexible coil produced on the mandrel is cut to a desired length of between about 4 and 100 cm after removal from the mandrel.
  • the coiled wire may then be wound on a larger diameter mandrel to form a helical winding as shown in Fig. 2 whose helix diameter, indicated at 14, is
  • the diameter of this secondary helical winding is preferably 1-3 cm, respectively. It can be appreciated from the above-mentioned wire lengths and winding
  • wires typically will contain 1-20 helical windings, more typically 4-8 helical windings as illustrated in Fig. 2.
  • the coil may further be preformed to contain irregularities in the helical winding, such that the coil adopts a folded, convoluted conformation in a relaxed condition as illustrated in Fig. 3.
  • the irregularities in this embodiment are such as to offset the helical axis (indicated by arrows in the figure) of each winding by 20-40 degrees.
  • the irregularities are preferably made by deforming, as by twisting, the coil in the region of desired bends with the coil on the helical winding mandrel.
  • the coil may treated by heating at about 800°F for about 24 hours for memory retention after it is shaped.
  • the combination of the helical winding and the irregularities in the winding cause the coil to form a randomly shaped, substantially space-filling mass when released into a vessel, as will be illustrated below.
  • the memory in the coil is effective to return the coil from a stretched, linear condition in which it is advanced through a catheter to a randomly oriented, space-filling relaxed condition as the coil is released from the catheter.
  • the coil just described may be thought of as having a primary structure formed by the wire wrapping making up. the coil, a secondary structure formed by the helical winding of the coil, and a tertiary structure formed by the irregularities in the winding of the coil. It will be appreciated that the random shape of the coil in its relaxed condition can be achieved by other, related secondary structures in the coil, such as a series of arcs which are interrupted at intervals by bends which orient the arcs in different directions.
  • the primary helical coil may be wound around a series of mandrels that are held in some uniform configuration to yield the offset helical shape shown in Fig. 3. Multiple coils may be formed in this way and thereafter the coils may be cut to form individual vasoocclusive coils.
  • the coil is preferably supplied in prepackaged form in a sterile cannula.
  • the cannula straightens the coil during shipment such that it can be placed within a catheter lumen for delivery to the targeted vessel.
  • a guidewire is inserted such that a catheter can be guided to the targeted vessel.
  • the guidewire is removed and the coil-containing cannula is placed into engagement with the proximal end of the catheter.
  • the coil is then transferred from the cannula lumen into the catheter lumen by exerting force on the proximal end of the coil.
  • the coil is advanced through the catheter to the tissue of interest by means a guidewire or coil pusher that pushes against the proximal end of the coil.
  • water may be injected into the catheter to force the coil through the catheter lumen.
  • the location of the coil may be visualized due to the radiopacity of the helical coil. Once at the site, the coil is plunged from the distal end of the catheter into the targeted vessel.
  • the coil is supplied in a cannula which is adapted to engage the proximal end of a guidewire. Once the guidewire and catheter are in place, the coil-containing cannula is placed into engagement with the proximal end of the guidewire and the coil is transferred from the cannula lumen onto the guidewire by exerting force on the
  • the coil is delivered to the targeted site by being pushed with a guidewire, coil pusher or by means of hydraulic injection as described above.
  • Figs, 1 to 9 show variants of the invention, but for simplicity of explanation, show the shape when the coil is in the catheter lumen (Figs. 1 and 7) and after release of the coil at the targeted site (Figs. 2 to 6, 8 and 9).
  • Fig. 2 shows a partial side view of the helical coil 10 in its relaxed configuration.
  • the coil 10 will be placed inside the catheter lumen in its linear stretched form (as shown in Fig. 1) until discharged from the end of the catheter at which time the configuration shown in Fig. 2 will be assumed.
  • Fig. 3 shows another embodiment of a vasoocclusive coil of the invention after it has been released from the end of the catheter.
  • the coil loops back upon itself to form a secondary coil having a tertiary configuration that may substantially fill the vessel to be occluded. Irregularities in the coil windings allow formation of the folded convoluted
  • Figs. 4, 5, and 6 each illustrate a different aspect of the invention.
  • Fig. 3 shows a helical coil that forms a tertiary shape that is circular
  • Figs. 4-6 show additional coils whose tertiary structures are also useful in the invention.
  • Fig. 4 shows a cloverleafshaped vasoocclusive coil
  • Fig. 5 shows a figure-8-shaped
  • Fig. 6 shows a C-shaped vasoocclusive coil.
  • the tertiary structures are the relaxed configurations of the coils after release into the vessel.
  • the devices are introduced as helical coils as shown in Fig. 1 and then assume the shapes shown.
  • the maximum helical coil diameters of the coils shown as 20, 22 and 24 are
  • Figures 7 and 8 show a vasoocclusive coil such as is described above, but in which irregularities in the helical winding are produced by flattening the wire coil in different directions. This may be accomplished by flattening or squeezing the linear coil 30 in a number of places 32 along the winding at various angles (if so desired) such as is shown in Fig. 7.
  • the coil so formed will have the general appearance shown in Fig. 7 when in its linear configuration.
  • the coil will be in its linear configuration as shown in Fig. 7 during its introduction into the vessel, but will assume the shape shown in Fig. 8 when in its relaxed configuration.
  • Fig. 9 shows a coil having a primary coil structure as described above, with a helical winding 40 having at least one helical turn whose diameter 42 is the size of the vessel to be occluded.
  • the irregularities in the helical winding take the form of continually changing helical diameters forming spirals which are dimensioned to span the cross-sectional area of the vessel.
  • the coils of the present invention therefore are useful for occluding vessels in the range of about 1 to 3 cm.
  • Such applications include the occlusion of fistulas of the pulmonary vasculature in the lungs, trauma in the periphery, arteriovenous malformations, heart anomalies and aneurysms.

Abstract

A device for occluding a large diameter (1 to 3 cm) vessel. The device comprises a helical coil (10) having a multiplicity of windings (14). The helical coil (10) may further be shaped into a variety of structures including a C-shape, a cloverleaf, and a figure 8.

Description

LARGE DIAMETER VASOOCCLUSION COIL
Description
Technical Field
This invention is in the general field of surgical instruments. More particularly, it relates to a vasoocclusion device that can be used in cardiovascular and endovascular procedures. Background
Vasoocclusion devices are surgical implements that are placed within vessels, typically via a catheter, to block the flow of blood through the vessel.
Vasoocclusive coils have been used to occlude vessels in small-diameter, difficult to reach sites. United States Patent No. 4,994,069 provides a vasoocclusive wire that is guided to a vessel that has a diameter of between 0.5 and 6 mm. The patent describes a flexible vasoocclusive wire that is designed to occlude a vessel when the wire is released into the vessel. The diameter of the coiled wire is between about 10-30 mils, the wire itself has an outside diameter of between about 2-6 mils and there are about 4-8 helical windings. For vasoocclusion of a vessel that is 0.5-2 mm, the wire has a preferred length of about 3-6 cm, and for a vessel that is 2-6 mm, the wire has a preferred length of about 5-10 cm.
The above described coils, therefore, are effective to occlude vessels of between about 0.5 and 6 mm which require tortuous path access. Where, however, the vessel is between about 1-3 cm, the coils were thought to be impractical as they would be too long to be reliable and might occlude neighboring vessels.
Disclosure of the Invention
It is therefore an object of the present invention to provide a vasoocclusive device that can be used to occlude large diameter vessels. The device is a vasoocclusive coil that assumes a linear helical
configuration when stretched and a folded convoluted configuration when relaxed. The stretched condition is used in placing the coil at the desired site and the coil assumes its relaxed configuration once the device is so placed.
The vasoocclusive device is a helical coil having a multiplicity of windings between a first and second end wherein the primary coil diameter is between about 0.25 and 1.5 mm and the diameter of the vessel to be occluded is between about 1.0 and 3.0 cm. Once relaxed, the coil may assume a secondary coil diameter approaching that of the selected vessel.
Brief Description of the Drawings
Figs. 1 to 9 are fragmentary elevational views (not to scale) of embodiments of the helical coil of the invention.
In the drawings, like structures are referred to by the same reference numeral.
Modes for Carrying Out the Invention
Fig. 1 depicts one embodiment, generally designated 10, of the helical vasoocclusive coil of the invention. The helical coil 10 will typically be made of a radiopaque material such as platinum, tungsten, gold, stainless steel, or of alloys such as tungsten and platinum. A tungsten-platinum alloy is preferred because of its strength and toughness. The material desirably is radiopaque and the diameter of the wire will usually be in the range of 0.05 to 0.25 mm. The coil has a
multiplicity of individual windings 12. The axial length of the coil will usually be in the range of 0.2 to 100 cm, more usually 0.2 to 40 cm and the diameter of the coil will normally be 0.25 and 1.5 mm, more usually 0.5 to 1.0 mm. The coil will typically have about 40 to 200 windings per cm, more typically about 50 to 130 windings per cm.
The steps in the construction of the vasoocclusion coils of this invention are shown in Figs. 1-3. The coil itself may be formed by wrappings of windings of a fine radiopaque wire thread, preferably 5 to 8 mil (0.13 to 0.20 mm) platinum, tungsten, gold, stainless steel or alloy thread which is available, for example, from California Fine Wire Company (Grover City, CA). The windings are preferably made by wrapping the thread on a spinning mandrel, according to known coilmanufacturing methods. The wire advance on the mandrel is adjusted to produce a single-layer coil with a minimum helical pitch, i.e., in which the windings are closely packed. Typically, the mandrel has a diameter of between about 0.10 and 1.0 mm yielding a coil whose outer
diameter is between about 0.25 and 1.5 mm. The soft, flexible coil produced on the mandrel is cut to a desired length of between about 4 and 100 cm after removal from the mandrel.
The coiled wire may then be wound on a larger diameter mandrel to form a helical winding as shown in Fig. 2 whose helix diameter, indicated at 14, is
approximately that of the vessel for which the coil is intended. The helical axis is indicated at 16. Thus for a wire designed for vasoocclusion of a vessel of about 1- 3 cm, the diameter of this secondary helical winding is preferably 1-3 cm, respectively. It can be appreciated from the above-mentioned wire lengths and winding
diameters, that the wires typically will contain 1-20 helical windings, more typically 4-8 helical windings as illustrated in Fig. 2.
The coil may further be preformed to contain irregularities in the helical winding, such that the coil adopts a folded, convoluted conformation in a relaxed condition as illustrated in Fig. 3. As seen, the irregularities in this embodiment are such as to offset the helical axis (indicated by arrows in the figure) of each winding by 20-40 degrees. The irregularities are preferably made by deforming, as by twisting, the coil in the region of desired bends with the coil on the helical winding mandrel. The coil may treated by heating at about 800°F for about 24 hours for memory retention after it is shaped.
According to an important feature of the invention, the combination of the helical winding and the irregularities in the winding cause the coil to form a randomly shaped, substantially space-filling mass when released into a vessel, as will be illustrated below. In particular, the memory in the coil is effective to return the coil from a stretched, linear condition in which it is advanced through a catheter to a randomly oriented, space-filling relaxed condition as the coil is released from the catheter.
The coil just described may be thought of as having a primary structure formed by the wire wrapping making up. the coil, a secondary structure formed by the helical winding of the coil, and a tertiary structure formed by the irregularities in the winding of the coil. It will be appreciated that the random shape of the coil in its relaxed condition can be achieved by other, related secondary structures in the coil, such as a series of arcs which are interrupted at intervals by bends which orient the arcs in different directions.
In an alternative method of manufacture, the primary helical coil may be wound around a series of mandrels that are held in some uniform configuration to yield the offset helical shape shown in Fig. 3. Multiple coils may be formed in this way and thereafter the coils may be cut to form individual vasoocclusive coils.
The coil is preferably supplied in prepackaged form in a sterile cannula. The cannula straightens the coil during shipment such that it can be placed within a catheter lumen for delivery to the targeted vessel.
A guidewire is inserted such that a catheter can be guided to the targeted vessel. Once the catheter is in place within a vessel, the guidewire is removed and the coil-containing cannula is placed into engagement with the proximal end of the catheter. The coil is then transferred from the cannula lumen into the catheter lumen by exerting force on the proximal end of the coil. The coil is advanced through the catheter to the tissue of interest by means a guidewire or coil pusher that pushes against the proximal end of the coil.
Alternatively, water may be injected into the catheter to force the coil through the catheter lumen. The location of the coil may be visualized due to the radiopacity of the helical coil. Once at the site, the coil is plunged from the distal end of the catheter into the targeted vessel.
In an alternative method in which the guidewire remains in place during coil ejection, the coil is supplied in a cannula which is adapted to engage the proximal end of a guidewire. Once the guidewire and catheter are in place, the coil-containing cannula is placed into engagement with the proximal end of the guidewire and the coil is transferred from the cannula lumen onto the guidewire by exerting force on the
proximal end of the coil. The coil is delivered to the targeted site by being pushed with a guidewire, coil pusher or by means of hydraulic injection as described above.
Figs, 1 to 9 show variants of the invention, but for simplicity of explanation, show the shape when the coil is in the catheter lumen (Figs. 1 and 7) and after release of the coil at the targeted site (Figs. 2 to 6, 8 and 9).
Fig. 2 shows a partial side view of the helical coil 10 in its relaxed configuration. Typically the coil 10 will be placed inside the catheter lumen in its linear stretched form (as shown in Fig. 1) until discharged from the end of the catheter at which time the configuration shown in Fig. 2 will be assumed.
Fig. 3 shows another embodiment of a vasoocclusive coil of the invention after it has been released from the end of the catheter. The coil loops back upon itself to form a secondary coil having a tertiary configuration that may substantially fill the vessel to be occluded. Irregularities in the coil windings allow formation of the folded convoluted
conformation in the coil's relaxed condition. As seen, the multiple convolutions or irregularities in the embodiment are such as to offset the helical axis (the arrows in Fig. 3) of each winding by 20-40 degrees.
Figs. 4, 5, and 6 each illustrate a different aspect of the invention. Whereas Fig. 3 shows a helical coil that forms a tertiary shape that is circular, Figs. 4-6 show additional coils whose tertiary structures are also useful in the invention. Fig. 4 shows a cloverleafshaped vasoocclusive coil, Fig. 5 shows a figure-8-shaped and Fig. 6 shows a C-shaped vasoocclusive coil. The tertiary structures are the relaxed configurations of the coils after release into the vessel. The devices are introduced as helical coils as shown in Fig. 1 and then assume the shapes shown. The maximum helical coil diameters of the coils shown as 20, 22 and 24 are
equivalent to the size of the vessel to be occluded, that is 1-3 cm.
Figures 7 and 8 show a vasoocclusive coil such as is described above, but in which irregularities in the helical winding are produced by flattening the wire coil in different directions. This may be accomplished by flattening or squeezing the linear coil 30 in a number of places 32 along the winding at various angles (if so desired) such as is shown in Fig. 7. The coil so formed will have the general appearance shown in Fig. 7 when in its linear configuration. The coil will be in its linear configuration as shown in Fig. 7 during its introduction into the vessel, but will assume the shape shown in Fig. 8 when in its relaxed configuration.
Fig. 9 shows a coil having a primary coil structure as described above, with a helical winding 40 having at least one helical turn whose diameter 42 is the size of the vessel to be occluded. In this variation, the irregularities in the helical winding take the form of continually changing helical diameters forming spirals which are dimensioned to span the cross-sectional area of the vessel.
The coils of the present invention, therefore are useful for occluding vessels in the range of about 1 to 3 cm. Such applications include the occlusion of fistulas of the pulmonary vasculature in the lungs, trauma in the periphery, arteriovenous malformations, heart anomalies and aneurysms.
Modifications of the above-described modes for carrying out the invention that are obvious to those of skill in the fields of medical device design generally, the vasoocclusion specifically are intended to be within the scope of the following claims.

Claims

Claims
1. A vasoocclusive device comprising a primary helical coil having a multiplicity of windings between a first and second end, wherein the diameter of the primary helical coil is between about 0.25 and 1.5 mm and the diameter of the vessel to be occluded is between about 1.0 and 3.0 cm.
2. The vasoocclusive device of claim 1 wherein the helical coil is from about 0.2 to 100 cm in length and has about 40-200 windings per cm.
3. The device of claim 1 wherein the helical coil assumes a secondary helical coil-shaped structure with between about 4-8 windings.
4. The device of claim 3 wherein the diameter of the secondary helical coil-shaped structure is between about 1.0 and 3.0 cm.
5. The device of claim 3 wherein the helical coil assumes a tertiary structure formed by
irregularities in the windings of the secondary helical coil-shaped structure.
6. The device of claim 1 wherein the helical coil assumes a secondary cloverleaf-shaped structure.
7. The device of claim 1 wherein the helical coil assumes a secondary figure 8-shaped structure.
8. The device of claim 1 wherein the helical coil assumes a secondary C-shaped structure.
9. The device of claim 1 wherein the helical coil assumes a secondary randomly-shaped structure.
10. The device of claim 9 wherein the
randomly-shaped structure forms a substantially spacefilling mass when released into the vessel.
11. The device of claim 1 wherein the helical coil assumes a secondary structure of continually changing helical diameters forming spirals.
12. The device of claim 11 wherein at least one spiral is dimensioned to span the cross-sectional area of the vessel to be occluded.
PCT/US1993/000882 1992-11-19 1993-02-03 Large diameter vasoocclusion coil WO1994011051A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002144725A CA2144725C (en) 1992-11-19 1993-02-03 Large diameter vasoocclusion coil
EP93904799A EP0743866A1 (en) 1992-11-19 1993-02-03 Large diameter vasoocclusion coil
AU36037/93A AU681073B2 (en) 1992-11-19 1993-02-03 Large diameter vasoocclusion coil
JP6512040A JPH08500273A (en) 1992-11-19 1993-02-03 Large diameter vasoocclusive coil

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97823092A 1992-11-19 1992-11-19
US07/978,230 1992-11-19

Publications (1)

Publication Number Publication Date
WO1994011051A1 true WO1994011051A1 (en) 1994-05-26

Family

ID=25525882

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1993/000882 WO1994011051A1 (en) 1992-11-19 1993-02-03 Large diameter vasoocclusion coil

Country Status (6)

Country Link
EP (1) EP0743866A1 (en)
JP (1) JPH08500273A (en)
AU (1) AU681073B2 (en)
CA (1) CA2144725C (en)
IL (1) IL104870A0 (en)
WO (1) WO1994011051A1 (en)

Cited By (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5690671A (en) * 1994-12-13 1997-11-25 Micro Interventional Systems, Inc. Embolic elements and methods and apparatus for their delivery
US5709224A (en) * 1995-06-07 1998-01-20 Radiotherapeutics Corporation Method and device for permanent vessel occlusion
US6145505A (en) * 1995-06-07 2000-11-14 Conceptus, Inc. Electrically affixed transcervical fallopian tube occlusion devices
US6270495B1 (en) 1996-02-22 2001-08-07 Radiotherapeutics Corporation Method and device for enhancing vessel occlusion
US6348041B1 (en) 1999-03-29 2002-02-19 Cook Incorporated Guidewire
US6526979B1 (en) 1995-06-07 2003-03-04 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and methods
US6551340B1 (en) 1998-10-09 2003-04-22 Board Of Regents The University Of Texas System Vasoocclusion coil device having a core therein
WO2003039376A1 (en) * 2001-11-07 2003-05-15 Microvention, Inc. Microcoil vaso-occlusive device with multi-axis secondary configuration
US6589227B2 (en) 2000-01-28 2003-07-08 William Cook Europe Aps Endovascular medical device with plurality of wires
US6605101B1 (en) 2000-09-26 2003-08-12 Microvention, Inc. Microcoil vaso-occlusive device with multi-axis secondary configuration
US6709667B1 (en) 1999-08-23 2004-03-23 Conceptus, Inc. Deployment actuation system for intrafallopian contraception
US6763833B1 (en) 1999-08-23 2004-07-20 Conceptus, Inc. Insertion/deployment catheter system for intrafallopian contraception
US6776788B1 (en) 1996-09-03 2004-08-17 William Cook, Europe A/S Embolization device for positioning in a blood vessel
EP1554983A1 (en) * 2004-01-16 2005-07-20 Medico's Hirata Inc. Bioabsorbable vasoocclusive coil
US7029486B2 (en) 2000-09-26 2006-04-18 Microvention, Inc. Microcoil vaso-occlusive device with multi-axis secondary configuration
US7033374B2 (en) 2000-09-26 2006-04-25 Microvention, Inc. Microcoil vaso-occlusive device with multi-axis secondary configuration
US8864790B2 (en) 2006-04-17 2014-10-21 Covidien Lp System and method for mechanically positioning intravascular implants
US9011480B2 (en) 2012-01-20 2015-04-21 Covidien Lp Aneurysm treatment coils
US9050095B2 (en) 2004-09-22 2015-06-09 Covidien Lp Medical implant
US9198665B2 (en) 2004-09-22 2015-12-01 Covidien Lp Micro-spiral implantation device
CN105286937A (en) * 2001-11-07 2016-02-03 微温森公司 Vascular obstruction device
US9289215B2 (en) 2007-03-13 2016-03-22 Covidien Lp Implant including a coil and a stretch-resistant member
US9579104B2 (en) 2011-11-30 2017-02-28 Covidien Lp Positioning and detaching implants
US9636118B2 (en) 2014-02-27 2017-05-02 Incumedx, Inc. Embolic framing microcoils
CN106659505A (en) * 2014-07-25 2017-05-10 因库麦迪斯有限公司 Covered embolic coils
US9687245B2 (en) 2012-03-23 2017-06-27 Covidien Lp Occlusive devices and methods of use
US9713475B2 (en) 2014-04-18 2017-07-25 Covidien Lp Embolic medical devices
US10307168B2 (en) 2015-08-07 2019-06-04 Terumo Corporation Complex coil and manufacturing techniques

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100015521A (en) 2007-03-13 2010-02-12 마이크로 테라퓨틱스 인코포레이티드 An implant, a mandrel, and a method of forming an implant

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4994069A (en) * 1988-11-02 1991-02-19 Target Therapeutics Vaso-occlusion coil and method

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD158084A1 (en) * 1981-05-08 1982-12-29 Joachim Heinke CLOSURE BODY AND METHOD FOR ITS MANUFACTURE
AU629658B2 (en) * 1990-04-26 1992-10-08 Semyon Gurevich A catheter device for the insertion of a dilator prosthesis into tubular organs of humans or animals

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4994069A (en) * 1988-11-02 1991-02-19 Target Therapeutics Vaso-occlusion coil and method

Cited By (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6165198A (en) * 1994-12-13 2000-12-26 Medtronic, Inc. Embolic elements and methods and apparatus for their delivery
US5690671A (en) * 1994-12-13 1997-11-25 Micro Interventional Systems, Inc. Embolic elements and methods and apparatus for their delivery
US6634361B1 (en) 1995-06-07 2003-10-21 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and methods
US6705323B1 (en) 1995-06-07 2004-03-16 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and methods
US6077261A (en) * 1995-06-07 2000-06-20 Radiotherapeutics Corporation Device for permanent vessel occlusion
US5709224A (en) * 1995-06-07 1998-01-20 Radiotherapeutics Corporation Method and device for permanent vessel occlusion
US6526979B1 (en) 1995-06-07 2003-03-04 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and methods
US7686020B2 (en) 1995-06-07 2010-03-30 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and methods
US6145505A (en) * 1995-06-07 2000-11-14 Conceptus, Inc. Electrically affixed transcervical fallopian tube occlusion devices
US8066007B2 (en) 1995-06-07 2011-11-29 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and their delivery
US6270495B1 (en) 1996-02-22 2001-08-07 Radiotherapeutics Corporation Method and device for enhancing vessel occlusion
US6656173B1 (en) 1996-02-22 2003-12-02 Radio Therapeutics Corporation Method and device for enhancing vessel occlusion
US7892254B2 (en) 1996-09-03 2011-02-22 William Cook, Europe A/S Embolization method for endovascular occlusion
US6776788B1 (en) 1996-09-03 2004-08-17 William Cook, Europe A/S Embolization device for positioning in a blood vessel
US8733360B2 (en) 1997-09-24 2014-05-27 Bayer Essure Inc. Occlusion devices and methods
US6551340B1 (en) 1998-10-09 2003-04-22 Board Of Regents The University Of Texas System Vasoocclusion coil device having a core therein
US6348041B1 (en) 1999-03-29 2002-02-19 Cook Incorporated Guidewire
US7591268B2 (en) 1999-08-23 2009-09-22 Conceptus, Inc. Deployment actuation system for intrafallopian contraception
US7506650B2 (en) 1999-08-23 2009-03-24 Conceptus, Inc. Deployment actuation system for intrafallopian contraception
US9597224B2 (en) 1999-08-23 2017-03-21 Bayer Healthcare Llc Deployment actuation system
US7237552B2 (en) 1999-08-23 2007-07-03 Conceptus, Inc. Insertion/deployment catheter system for intrafallopian contraception
US6709667B1 (en) 1999-08-23 2004-03-23 Conceptus, Inc. Deployment actuation system for intrafallopian contraception
US6763833B1 (en) 1999-08-23 2004-07-20 Conceptus, Inc. Insertion/deployment catheter system for intrafallopian contraception
US7025758B2 (en) 2000-01-28 2006-04-11 William Cook Europe Aps Endovascular medical device with plurality of wires
US6589227B2 (en) 2000-01-28 2003-07-08 William Cook Europe Aps Endovascular medical device with plurality of wires
US7331974B2 (en) 2000-09-26 2008-02-19 Microvention, Inc. Microcoil vaso-occlusive device with multi-axis secondary configuration
US7033374B2 (en) 2000-09-26 2006-04-25 Microvention, Inc. Microcoil vaso-occlusive device with multi-axis secondary configuration
US7029486B2 (en) 2000-09-26 2006-04-18 Microvention, Inc. Microcoil vaso-occlusive device with multi-axis secondary configuration
US8323306B2 (en) 2000-09-26 2012-12-04 Microvention, Inc. Microcoil vaso-occlusive device with multi-axis secondary configuration
US6605101B1 (en) 2000-09-26 2003-08-12 Microvention, Inc. Microcoil vaso-occlusive device with multi-axis secondary configuration
WO2003039376A1 (en) * 2001-11-07 2003-05-15 Microvention, Inc. Microcoil vaso-occlusive device with multi-axis secondary configuration
AU2002236676B2 (en) * 2001-11-07 2008-02-28 Microvention, Inc. Microcoil vaso-occlusive device with multi-axis secondary configuration
CN105286937A (en) * 2001-11-07 2016-02-03 微温森公司 Vascular obstruction device
EP2163212A1 (en) * 2001-11-07 2010-03-17 Microvention, Inc. Microcoil vaso-occlusive device with multi-axis secondary configuration
EP1554983A1 (en) * 2004-01-16 2005-07-20 Medico's Hirata Inc. Bioabsorbable vasoocclusive coil
US9050095B2 (en) 2004-09-22 2015-06-09 Covidien Lp Medical implant
US9198665B2 (en) 2004-09-22 2015-12-01 Covidien Lp Micro-spiral implantation device
US8864790B2 (en) 2006-04-17 2014-10-21 Covidien Lp System and method for mechanically positioning intravascular implants
US9289215B2 (en) 2007-03-13 2016-03-22 Covidien Lp Implant including a coil and a stretch-resistant member
US10335155B2 (en) 2011-11-30 2019-07-02 Covidien Lp Positioning and detaching implants
US9579104B2 (en) 2011-11-30 2017-02-28 Covidien Lp Positioning and detaching implants
US9011480B2 (en) 2012-01-20 2015-04-21 Covidien Lp Aneurysm treatment coils
US10893868B2 (en) 2012-01-20 2021-01-19 Covidien Lp Aneurysm treatment coils
US9687245B2 (en) 2012-03-23 2017-06-27 Covidien Lp Occlusive devices and methods of use
US9980734B2 (en) 2014-02-27 2018-05-29 Incumedx, Inc. Embolic framing microcoils
US10098645B2 (en) 2014-02-27 2018-10-16 Incumedx, Inc. Embolic framing microcoils
US9636118B2 (en) 2014-02-27 2017-05-02 Incumedx, Inc. Embolic framing microcoils
US9713475B2 (en) 2014-04-18 2017-07-25 Covidien Lp Embolic medical devices
CN106659505A (en) * 2014-07-25 2017-05-10 因库麦迪斯有限公司 Covered embolic coils
US9987015B2 (en) 2014-07-25 2018-06-05 Incumedx, Inc. Covered embolic coils
CN106659505B (en) * 2014-07-25 2019-07-02 因库麦迪斯有限公司 Embolic coil with veil
US10307168B2 (en) 2015-08-07 2019-06-04 Terumo Corporation Complex coil and manufacturing techniques

Also Published As

Publication number Publication date
CA2144725A1 (en) 1994-05-26
JPH08500273A (en) 1996-01-16
CA2144725C (en) 2000-06-06
AU681073B2 (en) 1997-08-21
IL104870A0 (en) 1993-06-10
AU3603793A (en) 1994-06-08
EP0743866A4 (en) 1996-07-26
EP0743866A1 (en) 1996-11-27

Similar Documents

Publication Publication Date Title
CA2144725C (en) Large diameter vasoocclusion coil
US5957948A (en) Three dimensional in-filling vaso-occlusive coils
US5549624A (en) Fibered vasooclusion coils
EP1009294B1 (en) Anatomically shaped vaso-occlusive device
US6860893B2 (en) Stable coil designs
US6001092A (en) Complex coils having fibered centers
JP2908363B2 (en) Bioactive occlusion coil
US8226660B2 (en) Vaso-occlusive coils with non-overlapping sections
US6544275B1 (en) Vaso-occlusive coils with selectively flattened areas
EP1307149A2 (en) Method of making vaso-occlusive coils

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU CA FI HU JP KR NO NZ PT

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1993904799

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2144725

Country of ref document: CA

WWP Wipo information: published in national office

Ref document number: 1993904799

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1993904799

Country of ref document: EP